Posted on 10/23/2015 1:21:16 AM PDT by grundle
A specialty drug company says it can offer a cheap alternative to compete with Turing CEO Martin Shkreli's controversial $750 pill that sparked outrage after the price was dramatically increased.
San Diego-based Imprimis Pharmaceuticals says it can make a close, customized version of the drug for $1 a pill. That's a big contrast to the $750-a-dose that Shkreli said Turing was going to start charging for Daraprim, which fights parasitic infections.
The Infectious Diseases Society of America and the HIV Medicine Association estimated it would cost $336,000 a year to treat someone with toxoplasmosis at that price.
(Excerpt) Read more at nbcnews.com ...
The invisible hand just flipped Shkreli the bird.
Yet songs that were written 100 years ago are still making money for Time-Lies-Warner-Turner.
“Happy birthday toooooo youuuuuuuu”
Very interesting. Looks like Shkreli gambled and lost. Maybe he thought insurance companies would just pay whatever he charged.
That was declared to be in the public domain just recently.
In an actual free market no government would confer upon Shkreli a monopoly for a chemical compound, and thus he could not charge his monopoly price.
Anyone know how “close” a “close” version is?
How long will the FDA insist on testing it?
That's always an issue with any generic or compounded drug. You have to trust your pharmacist! Some people say they have a different reaction to a generic version than to a name-branded drug, though that's never happened to me.
The article said that the low-cost version will contain an added ingredient intended to reduce unpleasant side effects, so it's not being sold as an exact equivalent of the branded drug.
Why bother testing it?
Obamacare shields generic manufacturers from lawsuits over sideeffects and holds the creator/discoverer accountable.
http://www.reuters.com/article/2013/06/24/usa-court-generics-idUSL2N0F00K820130624
Markets | Mon Jun 24, 2013 4:51pm EDT Related: Stocks, Markets, Healthcare
UPDATE 3-U.S. justices block generic drug liability lawsuits
The U.S. Supreme Court ruled on Monday that generic drugmakers cannot be sued under state law for adverse reactions to their products, a decision that consumer advocates called a blow to patient safety.
...The majority opinion, written by Justice Samuel Alito, said the state’s law could not run against federal laws on prescription medicines whose design has been approved by the U.S. Food and Drug Administration.
A Supreme Court ruling in 2011 found that pharmaceutical companies that make branded drugs are liable for inadequacies in safety warnings of a medicine’s label, but not the makers of cheaper copies of those medicines...
Mutual, backed by the Obama administration, said federal law trumped state law claims such as those Bartlett had made, pointing to the fact that the drug had already won FDA approval with an agency-approved label carrying safety warnings...
US patients are being forced to use generics by their insurance companies while those in Canada get US-customer subsidized pricing of the genuine article.
We sometimes get Chinese made crud that isn’t even close.
This is the side effects of the drug, http://www.rxlist.com/daraprim-drug/consumer-uses.htm, when you add in another ingredient it may make it worse. Even changing the dye can cause issues. Since it has 2 names, the second is a generic.
PYRIMETHAMINE - ORAL (pir-ih-METH-uh-meen)
COMMON BRAND NAME(S): Daraprim
NORCO found that out when they were Mandated to lower the Tylenol in Loretabs, which then became NORCO. The 10 mg was pink, the new one is lemon yellow. All they were required to do was lower the Tylenol. Yet people are having reactions to the lemon yellow dye of the 10 mg tablet. It’s not fun having your head in the toilet for 4 hrs puking until you have dry heaves, until the crap wears off. Been there done that. Doctor now has to prescribe double the amount of the white 5 mg tablets to do the same job.
And it’s not just Patent Drug makers, it is also doctors pushing the crap, they push the latest highest priced stuff. Then they ignore the FDA to issue warnings to the patient to the dangers of the drugs. OP drugs especially are a huge money maker. When you inform your dentist you are on a OP drug, especially Fosamax, they can refuse to treat you. Jaw degeneration is the reason. And you can’t fool them, they will know from the condition of your teeth and jaw.
Safety update for osteoporosis drugs, bisphosphonates, and atypical femur fractures, A FIB, Jaw Degeneration, A-typical femur fractures, GI issues,Kidney failure deaths. The IV Reclast is the worst of the lot. Do not take if you have asthma. Reclast UPS kidney failure, A FIB risk. Not to be given to Asthma patients.
http://www.webmd.com/osteoporosis/news/20110901/fda-osteoporsis-drug_ups-kidney-failure-risk
http://www.fda.gov/drugs/drugsafety/drugsafetypodcasts/ucm229800.htm
Black box warning Foreto (this drug reverses all gains after the 2 year time frame.)
http://www.medicinenet.com/script/main/art.asp?articlekey=21853
Amazon carries both books, first one is all natural second is a blend of drugs and natural.
Your Bones: How You Can Prevent Osteoporosis and Have Strong Bones for Life - Naturally Lara Pizzorno 2013
The Whole Body Approach to OP
R. Keith McCormick
Still subject to FDA approval.
The issue with drug costs is NEVER the cost of producing the drug. Virtually all drugs have production costs near zero.
The cost of selling drugs is determined by the cost of government approvals required in order to sell the drugs. It takes years of testing and billions of dollars to get the approval. In the mean time, Shkreli is the sole supplier.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.